ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN ROWLETT MD

Internal Medicine

786

$11.6K

457
243 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 26%

$15
Average prescription price

Avg: $56

GERMAN GARCIA MD

Internal Medicine

4,863

$232K

187
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

JONATHAN VELASQUEZ MD

Internal Medicine

447

$6,014

234
101 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 26%

$13
Average prescription price

Avg: $56

DAVID ROWAN

Internal Medicine

607

$29.6K

64
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

NAREN LOGENDRA M.D.

Internal Medicine

595

$10.6K

340
164 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 26%

$18
Average prescription price

Avg: $56

PALGHAT MOHAN M.D

Internal Medicine

21,061

$1.07M

402
330 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

42%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

DENNIS HARPER MD

Internal Medicine

19,174

$871K

482
309 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

JAMES COBB M.D.

Internal Medicine

21,159

$883K

599
444 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

JEANPHIS LAGUERRE MD

Internal Medicine

12,401

$608K

385
201 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

ANTHONY HOWARD M.D.

Internal Medicine

29,913

$1.48M

543
345 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

41%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

DAVID KAVTARADZE M.D.

Internal Medicine

44,656

$3.06M

1002
718 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $56

RALPH JACKSON MD

Internal Medicine

10,982

$673K

532
316 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

DOUGLAS MOSS MD

Internal Medicine

21,898

$1.33M

511
351 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

SOFIA ZAMAN M.D.

Internal Medicine

969

$37.7K

77
64 are 65+

34%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

PATRICIA GLENN M.D

Internal Medicine

13,664

$830K

420
247 are 65+

25%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

ROMEL CUNANAN MD

Internal Medicine

3,617

$206K

124
58 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

HUMA AHMED MD

Internal Medicine

3,058

$283K

378
227 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$92
Average prescription price

Avg: $56

MARK BRULTE MD

Internal Medicine

7,867

$438K

571
309 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

KARUNAKER SRIPATHI MD

Internal Medicine

14,543

$765K

403
259 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

ASHFAQ SAIYED M.D.

Internal Medicine

22,209

$910K

537
309 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $56

KAUSHIK AMIN MD

Internal Medicine

25,549

$1.48M

806
482 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

JAMES PARKS MD

Internal Medicine

16,739

$786K

236
209 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

JOHN DEMICCO M.D.

Internal Medicine

12,091

$1.14M

437
270 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$94
Average prescription price

Avg: $56

MARSHALL TANNER M.D.

Internal Medicine

21,323

$1.31M

819
507 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

SAQIB NAZIR M.D.

Internal Medicine

28,401

$1.31M

794
384 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank